norfloxacin has been researched along with Body Weight in 5 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Forty-six pregnant monkeys were dosed with a control vehicle or 200 mg/kg/day norfloxacin for one of three 10-day periods on GD 36-45, 71-80, or 111-120." | 1.28 | Embryotoxicity studies of norfloxacin in cynomolgus monkeys: I. Teratology studies and norfloxacin plasma concentration in pregnant and nonpregnant monkeys. ( Cukierski, MA; Cukierski, MJ; Hess, DL; Nyland, T; Peter, CP; Prahalada, S; Robertson, RT; Rodgers, JD; Tarantal, AF; Zacchei, AG, 1989) |
| "Norfloxacin is a new antibiotic which caused embryo-fetal toxicity in association with maternotoxicity when given orally to rabbits at 100 mg/kg/day." | 1.27 | Association between adverse maternal and embryo-fetal effects in norfloxacin-treated and food-deprived rabbits. ( Bland, JA; Bokelman, DL; Clark, RL; Nolan, TE; Oppenheimer, L; Peter, CP; Robertson, RT, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, C | 1 |
| Tian, Y | 1 |
| Yu, J | 1 |
| Zhang, R | 1 |
| Zhang, X | 1 |
| Guo, P | 1 |
| Nita, LE | 1 |
| Chiriac, AP | 1 |
| Nistor, MT | 1 |
| Tartau, L | 1 |
| Sumano, LH | 1 |
| Ocampo, CL | 1 |
| Brumbaugh, GW | 1 |
| Lizarraga, RE | 1 |
| Cukierski, MA | 1 |
| Prahalada, S | 1 |
| Zacchei, AG | 1 |
| Peter, CP | 2 |
| Rodgers, JD | 1 |
| Hess, DL | 1 |
| Cukierski, MJ | 1 |
| Tarantal, AF | 1 |
| Nyland, T | 1 |
| Robertson, RT | 2 |
| Clark, RL | 1 |
| Bland, JA | 1 |
| Nolan, TE | 1 |
| Oppenheimer, L | 1 |
| Bokelman, DL | 1 |
1 trial available for norfloxacin and Body Weight
| Article | Year |
|---|---|
Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers.
Topics: Animals; Anti-Infective Agents; Body Weight; Chickens; Chronic Disease; Disease Outbreaks; Enrofloxa | 1998 |
4 other studies available for norfloxacin and Body Weight
| Article | Year |
|---|---|
The pandanus tectorius fruit extract (PTF) modulates the gut microbiota and exerts anti-hyperlipidaemic effects.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteroidetes; Blood Glucose; Body Weight; Diet, High-Fa | 2019 |
Upon some multi-membrane hydrogels based on poly(N,N-dimethyl-acrylamide-co-3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5) undecane): preparation, characterization and in vivo tests.
Topics: Acrylic Resins; Alkanes; Ammonia; Biocompatible Materials; Body Weight; Citrates; Cross-Linking Reag | 2014 |
Embryotoxicity studies of norfloxacin in cynomolgus monkeys: I. Teratology studies and norfloxacin plasma concentration in pregnant and nonpregnant monkeys.
Topics: Animals; Body Weight; Embryonic and Fetal Development; Female; Macaca fascicularis; Maternal-Fetal E | 1989 |
Association between adverse maternal and embryo-fetal effects in norfloxacin-treated and food-deprived rabbits.
Topics: Animals; Bile; Body Weight; Embryonic and Fetal Development; Female; Fetal Resorption; Food Deprivat | 1986 |